ASTROCYTES
![]() |
![]() |
| Astrocytes around capillary-GFAP | Astrocyte-GFAP |
Astrocytes (star cells) have radially arranged processes. Their cytoplasm contains intermediate filaments composed of a distinct protein, glial fibrillary acidic protein (GFAP). Antibodies against this protein are routinely used to demonstrate reactive and neoplastic astrocytes. Historically, GFAP was the first immunostain to be used. During brain development, astrocytic processes (radial glia) guide neurons in their migration from the wall of the ventricles to the cortex. Radial glia are also a source of neuronal and astrocytic stem cells in the developing brain.
![]() |
![]() |
| Glia limitans | Astrocytic processes around capillary |
Astrocytic foot processes surround brain capillaries and, during development, induce endothelial cells to form tight junctions. The endothelial tight junctions are the basis of the blood-brain barrier, a system of controlled transcapillary transport which maintains homeostasis in the CNS. Endothelial tight junctions are found only in brain capillaries. Loss of the integrity of the endothelial barrier causes fluid to leak into the interstitial space, leading to vasogenic cerebral edema. This raises intracranial pressure and can collapse brain capillaries, resulting in arrest of cerebral perfusion. Cerebral edema is caused by a variety of pathological processes, including ischemic insults, inflammation, and malignant brain tumors whose capillaries do not have tight junctions. Astrocytes are less vulnerable than neurons to ischemic injury but they are damaged if there is lactic acidosis. Such damage causes intracellular fluid accumulation (cytotoxic edema). Cytotoxic edema involves the cerebral cortex, whereas vasogenic edema is more pronounced in the white matter. Vasogenic edema is more important clinically than cytotoxic edema.
Through their extensive contacts and interactions with neurons and vessels astrocytes play a very important role in the function of the CNS in addition to providing structural support. They take up K+ that is released during neuronal activity thus maintaining ion balance in the extracellular fluid. The small amount of glycogen that is present in astrocytes is the only form of stored energy in the CNS and can be used when neuronal activity demands it. More important, the coupling of astrocytes to synapses and vessels facilitates the entry of glucose into the CNS in response to neuronal activity. They take up and recycle GABA and glutamate that are released at synaptic clefts. Glutamate is converted to glutamine by glutamine synthetase. Glutamine is then released into the extracellular space, taken up by neurons, and converted to glutamate by glutaminase. Astrocytes also produce new glutamate from glucose via the tricarboxylic acid cycle. This replenishes glutamate lost through oxidative degradation. Without astrocytes, neurons would not have their most important neurotransmitter. In addition, astrocytes influence synaptic activity by releasing glutamate directly into the extracellular space.
![]() |
![]() |
![]() |
| Gemistocytic astrocytes | Reactive astrocytes-GFAP | Alzheimer II astrocytes |
![]() |
![]() |
![]() |
| Rosental fibers | Rosental fiber-EM | Corpora amylacea |
Rosenthal fibers are homogeneous, eosinophilic, elongated, or globular inclusions in astrocytic processes. They have a filamentous and granular structure and contain GFAP. They are seen in old brain scars dating back to childhood, and in some low-grade astrocytomas. Mutations of GFAP cause Alexander disease, characterized by diffuse deposition of Rosenthal fibers, resulting in white matter degeneration and neurological dysfunction. Corpora amylacea are spherical intracytoplasmic bodies of carbohydrate polymers that develop in astrocytic processes with advancing age. They have no pathological significance. The astrocyte is the cell in the adult mammalian brain most capable of undergoing mitosis. Most brain tumors are derived from astrocytes (astrocytomas).
Further reading
Benarroch EE. Neuron-Astrocyte Interactions: Partnership for Normal Function and Disease in the Central Nervous System. Mayo Clin Proc 2005;80:1326-38. PubMed
Kettenmann H, Verkhratsky A. Neuroglia: the 150 years after. Trends in Neurosciences 2008;31:653-59. PubMed
Updated: December, 2008










